Titre : Syndrome de Budd-Chiari

Syndrome de Budd-Chiari : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lithotripsy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndrome de Budd-Chiari : Questions médicales les plus fréquentes", "headline": "Syndrome de Budd-Chiari : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndrome de Budd-Chiari : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-11", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndrome de Budd-Chiari" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thrombose veineuse", "url": "https://questionsmedicales.fr/mesh/D020246", "about": { "@type": "MedicalCondition", "name": "Thrombose veineuse", "code": { "@type": "MedicalCode", "code": "D020246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.355.830.925" } } }, "about": { "@type": "MedicalCondition", "name": "Syndrome de Budd-Chiari", "alternateName": "Budd-Chiari Syndrome", "code": { "@type": "MedicalCode", "code": "D006502", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None Shalimar", "url": "https://questionsmedicales.fr/author/None%20Shalimar", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Akash Shukla", "url": "https://questionsmedicales.fr/author/Akash%20Shukla", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India." } }, { "@type": "Person", "name": "Joseph J Alukal", "url": "https://questionsmedicales.fr/author/Joseph%20J%20Alukal", "affiliation": { "@type": "Organization", "name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Talan Zhang", "url": "https://questionsmedicales.fr/author/Talan%20Zhang", "affiliation": { "@type": "Organization", "name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Paul J Thuluvath", "url": "https://questionsmedicales.fr/author/Paul%20J%20Thuluvath", "affiliation": { "@type": "Organization", "name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Shockwave Intravascular Lithotripsy Facilitated Transvenous Lead Extraction.", "datePublished": "2023-05-18", "url": "https://questionsmedicales.fr/article/37278685", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jacep.2023.05.007" } }, { "@type": "ScholarlyArticle", "name": "Ureteroscopic Lithotripsy in Reverse Trendelenburg Position and Intraoperative Furosemide.", "datePublished": "2022-11-08", "url": "https://questionsmedicales.fr/article/35892148", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.22037/uj.v19i03.7163" } }, { "@type": "ScholarlyArticle", "name": "Defining the Learning Curve of Flexible Ureterorenoscopy and Laser Lithotripsy.", "datePublished": "2022-12-25", "url": "https://questionsmedicales.fr/article/36444766", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.22037/uj.v19i.7389" } }, { "@type": "ScholarlyArticle", "name": "Lithotripsy devices for percutaneous nephrolithotomy (PNL) - new developments.", "datePublished": "2022-06-09", "url": "https://questionsmedicales.fr/article/35674683", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MOU.0000000000000996" } }, { "@type": "ScholarlyArticle", "name": "Management of Calcification: Rational and Technical Considerations for Intravascular Lithotripsy.", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35842260", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tvir.2022.100841" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Embolie et thrombose", "item": "https://questionsmedicales.fr/mesh/D016769" }, { "@type": "ListItem", "position": 5, "name": "Thrombose", "item": "https://questionsmedicales.fr/mesh/D013927" }, { "@type": "ListItem", "position": 6, "name": "Thrombose veineuse", "item": "https://questionsmedicales.fr/mesh/D020246" }, { "@type": "ListItem", "position": 7, "name": "Syndrome de Budd-Chiari", "item": "https://questionsmedicales.fr/mesh/D006502" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndrome de Budd-Chiari - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndrome de Budd-Chiari", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndrome de Budd-Chiari", "description": "Comment diagnostiquer le syndrome de Budd-Chiari ?\nQuels tests sanguins sont utiles ?\nQuels signes cliniques indiquent ce syndrome ?\nL'échographie Doppler est-elle utile ?\nQuand envisager une biopsie hépatique ?", "url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Lithotripsy&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndrome de Budd-Chiari", "description": "Quels sont les symptômes courants ?\nLa douleur abdominale est-elle fréquente ?\nQu'est-ce que l'ascite ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?", "url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Lithotripsy&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndrome de Budd-Chiari", "description": "Comment prévenir le syndrome de Budd-Chiari ?\nLes anticoagulants peuvent-ils prévenir ce syndrome ?\nQuelles habitudes de vie adopter ?\nLes vaccinations sont-elles importantes ?\nFaut-il surveiller les maladies hépatiques ?", "url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Lithotripsy&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndrome de Budd-Chiari", "description": "Quels traitements sont disponibles ?\nQuand utiliser des anticoagulants ?\nQu'est-ce qu'une procédure endovasculaire ?\nQuand envisager une transplantation hépatique ?\nY a-t-il des traitements symptomatiques ?", "url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Lithotripsy&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndrome de Budd-Chiari", "description": "Quelles sont les complications possibles ?\nL'insuffisance hépatique est-elle fréquente ?\nQu'est-ce que l'hypertension portale ?\nPeut-on avoir des complications à long terme ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Lithotripsy&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndrome de Budd-Chiari", "description": "Quels sont les principaux facteurs de risque ?\nL'obésité augmente-t-elle le risque ?\nLes maladies hépatiques sont-elles un risque ?\nLes contraceptifs oraux sont-ils un facteur ?\nLe tabagisme influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Lithotripsy&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le syndrome de Budd-Chiari ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'échographie, l'IRM et des tests sanguins pour évaluer la fonction hépatique." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les marqueurs de la fonction hépatique et les tests de coagulation." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent ce syndrome ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent l'ascite, la douleur abdominale et l'hypertrophie du foie." } }, { "@type": "Question", "name": "L'échographie Doppler est-elle utile ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'évaluer le flux sanguin dans les veines hépatiques et de détecter des obstructions." } }, { "@type": "Question", "name": "Quand envisager une biopsie hépatique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie peut être envisagée si le diagnostic est incertain ou pour évaluer des lésions hépatiques." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleur abdominale, jaunisse et ascite." } }, { "@type": "Question", "name": "La douleur abdominale est-elle fréquente ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur abdominale est un symptôme fréquent, souvent localisée dans la partie supérieure droite." } }, { "@type": "Question", "name": "Qu'est-ce que l'ascite ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'ascite est l'accumulation de liquide dans la cavité abdominale, souvent causée par une hypertension portale." } }, { "@type": "Question", "name": "La jaunisse est-elle un symptôme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la jaunisse, due à une accumulation de bilirubine, est un symptôme courant du syndrome." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes asymptomatiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent être asymptomatiques, surtout dans les formes chroniques." } }, { "@type": "Question", "name": "Comment prévenir le syndrome de Budd-Chiari ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut la gestion des facteurs de risque comme les troubles de la coagulation et l'obésité." } }, { "@type": "Question", "name": "Les anticoagulants peuvent-ils prévenir ce syndrome ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent prévenir les thromboses chez les patients à risque." } }, { "@type": "Question", "name": "Quelles habitudes de vie adopter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac sont bénéfiques." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, se faire vacciner contre l'hépatite peut réduire le risque de complications hépatiques." } }, { "@type": "Question", "name": "Faut-il surveiller les maladies hépatiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, surveiller les maladies hépatiques et les troubles de la coagulation est crucial pour la prévention." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des anticoagulants, des procédures endovasculaires et, dans certains cas, une transplantation hépatique." } }, { "@type": "Question", "name": "Quand utiliser des anticoagulants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les anticoagulants sont utilisés pour traiter les thromboses veineuses hépatiques et prévenir les complications." } }, { "@type": "Question", "name": "Qu'est-ce qu'une procédure endovasculaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est une intervention pour débloquer les veines hépatiques, souvent par angioplastie ou stenting." } }, { "@type": "Question", "name": "Quand envisager une transplantation hépatique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications irréversibles." } }, { "@type": "Question", "name": "Y a-t-il des traitements symptomatiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements symptomatiques comme les diurétiques peuvent aider à gérer l'ascite." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance hépatique, la thrombose et l'hypertension portale." } }, { "@type": "Question", "name": "L'insuffisance hépatique est-elle fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'insuffisance hépatique est une complication grave pouvant survenir dans ce syndrome." } }, { "@type": "Question", "name": "Qu'est-ce que l'hypertension portale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'hypertension portale est une augmentation de la pression dans la veine porte, causée par l'obstruction." } }, { "@type": "Question", "name": "Peut-on avoir des complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme comme la cirrhose peuvent se développer si non traitées." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un traitement précoce et une surveillance régulière." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent les troubles de la coagulation, l'obésité, et certaines maladies hépatiques." } }, { "@type": "Question", "name": "L'obésité augmente-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est un facteur de risque connu pour le syndrome de Budd-Chiari." } }, { "@type": "Question", "name": "Les maladies hépatiques sont-elles un risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies hépatiques, comme la cirrhose, augmentent le risque de ce syndrome." } }, { "@type": "Question", "name": "Les contraceptifs oraux sont-ils un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation prolongée de contraceptifs oraux peut augmenter le risque de thrombose." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut contribuer à des problèmes vasculaires, augmentant le risque de thrombose." } } ] } ] }

Sources (612 au total)

Shockwave Intravascular Lithotripsy Facilitated Transvenous Lead Extraction.

Dense calcifications encasing pacing leads with long dwell times are common and increase the difficulty of and risks associated with transvenous lead extraction procedures (TLE). Shockwave intravascul... This study sought to assess the impact of Shockwave IVL pretreatment during extraction of long dwell time pacemaker and defibrillator leads.... Data were compiled retrospectively from patients undergoing TLE at Essentia Health in Duluth, Minnesota, from October 2019 to April 2023. IVL pretreatment was performed using currently available 7- an... Of the 120 patients undergoing TLE procedures, 55 were excluded from the study because the leads were freely mobile. Among the remaining 65 patients, 14 received IVL pretreatment. The median patient a... These data represent the first known cases using Shockwave IVL as an adjunctive measure during extraction of high-risk and high-complexity leads, with a resulting significant reduction in the amount o...

Ureteroscopic Lithotripsy in Reverse Trendelenburg Position and Intraoperative Furosemide.

Upward stone migration is a significant problem during ureteroscopic lithotripsy (URSL) for upper ureteral stone, especially in absence of a ureteral occlusion device. In this study, we evaluated the ... From March 2018 to May 2020, a total of 119 URSLs were performed for upper ureteral stone (6-15 mm) with 67 procedures in RTP and 52 procedures in conventional lithotomy position (CLP). 20 mg of intra... Patient data, stone side and size were similar in the two groups. All procedures were complete without conversion to open surgery and major complications. There was no significant difference in the me... The strategy of placing the patient in RTP and intraoperative administration of intravenous furosemide is simple, feasible and cost-effective in preventing stone upward migration during URSL with holm...

Defining the Learning Curve of Flexible Ureterorenoscopy and Laser Lithotripsy.

To investigate the impact of learning curve (LC) on flexible ureterorenoscopy (f-URS).... Patients who underwent kidney stone surgery in a urology clinic from a tertiary health care institution with f-URS were enrolled in the study. Patient characteristics, the properties of kidney and kid... Time from the induction of anaesthesia to insertion of flexible ureterorenoscope was 18.6 min in group 1 and 17.2 min in group 2; then it significantly decreased to 15.0 min for cases 40 through 60 an... Flexible ureterorenoscopy is a surgery that requires high technique and experience. The present study found that success of f-URS reached satisfactory levels after 20th cases. In addition, 40 cases ma...

Lithotripsy devices for percutaneous nephrolithotomy (PNL) - new developments.

Percutaneous nephrolithotomy (PNL) is the mainstay of surgery for renal calculi>2 cm or complex multiple calculi and is a technique that has been around since 1976. We review recent literature surroun... At present, the Holmium:yttrium-aluminum-garnet (Ho:YAG) laser is widely accepted as the gold standard laser lithotripsy for PNL. SwissLithoClast Trilogy offers a range of probes with a trifecta of el... Trilogy, Shockpulse, TFL and Moses pulse modulation technology for the Holmium laser all provide improvements compared with older lithotripsy devices. In particular, they convey a safer, efficient and...

Are the current nomograms sufficient to predict shockwave lithotripsy outcomes?

To investigate factors affecting SWL outcomes, validate three current nomograms (Kim JK, Triple D and S3HoCKwave) and compare the predictive ability of the nomograms for SWL outcomes in upper urinary ... Medical records of patients with renal and proximal ureteral stones treated with SWL between March 2013 and October 2020 were retrospectively reviewed. Factors affecting SWL success were analyzed with... A total of 580 patients were included in our study. The overall stone free rate was 61% and 144/580 patients (24.8%) were stone free after one session. In multivariate logistic regression analysis, st... Stone location, number, maximal diameter, and maximum HU were independent predictive factors for SWL outcome in the treatment of upper urinary tract stones. Current nomograms, "Kim JK nomogram", "Trip...

Are Newer Extracorporeal Shock Wave Lithotripsy Models Truly Improving Pancreatolithiasis Lithotripsy Performance? A Japanese Single-Center Study Using Endoscopic Adjunctive Treatment.

Many Japanese institutions use electromagnetic extracorporeal shock wave lithotripsy (ESWL) systems for treating pancreatic duct stones. However, there are no reports on direct comparisons between rec... We retrospectively identified 208 patients with pancreatolithiasis who underwent endoscopic adjunctive treatment after pancreatic ESWL at a single Japanese center over a 17-year period. We evaluated t... For pancreatic head stones, ESWL disintegration was achieved in 93.7% of group A patients and 69.0% of group B patients (p=0.004), and adjunctive endoscopic treatment removed stones in 96.8% of group ... The SLX F2 showed high performance in fragmenting the pancreatic duct stones. In addition, endoscopic adjunctive treatment improved the overall success rate of the procedure. The improved ESWL lithotr...

Lasers for stone lithotripsy: advantages/disadvantages of each laser source.

The purpose of this article was to make a narrative review of the literature in search of all articles regarding thulium:yttrium-aluminium-garnet (YAG), thulium laser fiber (TFL) and holmium:YAG (Ho:Y... New Ho:YAG technologies of as high power, high frequency and pulsed modulations have shown promising results for lithotripsy by reducing retropulsion with good ablation efficiency. High peak power mak... Several new technologies have been developed in the last years for stone lithotripsy. All being efficient and safe if well used. Different advantages and disadvantages of each laser must be taken into...

Evaluating the role of urine chemistry in shock wave lithotripsy outcomes.

Extracorporeal Shock Wave Lithotripsy (ESWL) is a commonly used method for the noninvasive treatment of kidney stones. However, achieving optimal treatment outcomes and minimizing potential damage to ... Between January 2023 and December 2023, 129 patients with renal stones underwent SWL in our department using the Storz Medical Modulith Inline lithotripter. Stone-free rates, complications, and the im... Evaluation of our findings revealed a negative linear relationship between total amount of energy used and the urine pH, indicating a decrease in the total energy amount as urine pH shifts towards alk... Our findings demonstrated a significant relationship between urine pH and the total amount of energy applied during SWL sessions, suggesting the need for further prospective research to better underst...